Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes
Nanotheranostics · 2022 · 6 (3) · 230-242
DOI: 10.7150/ntno.61280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanotheranostics, 2022. Verfasst von Wafa' T Al-Jamal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nanomedicine Lab, UCL School of Pharmacy, University College London, Brunswick Square, London WC1N 1AX, United Kingdom. Hauptthemen laut MEDLINE: Hyperthermia, Induced, Melanoma. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanomedicine Lab, UCL School of Pharmacy, University College London, Brunswick Square, London WC1N 1AX, United Kingdom.
- School of Pharmacy, Queen's University Belfast, United Kingdom.
- Faculty of Medical &Human Sciences and National Graphene Institute, University of Manchester, Manchester, United Kingdom.
Zitieren
APA
Al-Jamal, W. T., & Kostarelos, K. (2022). Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes. Nanotheranostics, 6(3), 230-242. https://doi.org/10.7150/ntno.61280
Vancouver
Al-Jamal WT, Kostarelos K. Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes. Nanotheranostics. 2022;6(3):230-242. doi:10.7150/ntno.61280
BibTeX
@article{AlJamal2022,
author = {Al-Jamal, Wafa' T and Kostarelos, Kostas},
title = {Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes},
journal = {Nanotheranostics},
year = {2022},
volume = {6},
number = {3},
pages = {230--242},
doi = {10.7150/ntno.61280}
}
EUVIMED